Marshall Wace North America’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-14,856
| Closed | -$1.84M | – | 1823 |
|
|
2020
Q4 | $1.84M | Buy |
+14,856
| New | +$1.84M | 0.01% | 777 |
|
|
2020
Q2 | – | Sell |
-13,107
| Closed | -$1.89M | – | 1567 |
|
|
2020
Q1 | $1.89M | Buy |
+13,107
| New | +$1.89M | 0.01% | 493 |
|
|
2018
Q2 | – | Sell |
-19,473
| Closed | -$399K | – | 1782 |
|
|
2018
Q1 | $399K | Buy |
+19,473
| New | +$399K | ﹤0.01% | 1203 |
|